The present invention relates to antibody molecules against anticoagulants, in particular dabigatran,and their use as antidotes of such anticoagulants.La présente invention concerne des molécules danticorps contre les anticoagulants, notamment le dabigatran, et leur utilisation en tant quantidotes auxdits anticoagulants.